Atia Vision, Inc. is a clinical-stage ophthalmic medical device company headquartered in Campbell, California, and a portfolio company of the Shifamed medical innovation hub. It develops the OmniVu modular shape-changing intraocular lens (IOL) — a two-part implant pairing a fluid-filled, shape-changing base with an exchangeable fixed-power front optic — designed to work with the eye's natural accommodative mechanism to restore a full range of functional vision in cataract patients, and implanted using conventional cataract surgical technique. The company raised a $20M Series D and a $42M Series E, and in May 2025 the U.S. Food and Drug Administration granted it an Investigational Device Exemption to begin a feasibility clinical study of the OmniVu Lens System; the device is investigational and is not approved for sale or use in the United States. Atia Vision is an implantable-device manufacturer: it publishes no developer program, no public API, and no machine-readable specification.
Atia Vision is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Ophthalmology, Intraocular Lens, and Cataract Surgery.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/atia-vision: open an issue to ask a question, or submit a pull request to add artifacts.
Submit an artifact on GitHub — free →Manage your own listing — the Influence plan, $499/mo →
aid: atia-vision
name: Atia Vision
description: 'Atia Vision, Inc. is a clinical-stage ophthalmic medical device company headquartered in Campbell, California,
and a portfolio company of the Shifamed medical innovation hub. It develops the OmniVu modular shape-changing intraocular
lens (IOL) — a two-part implant pairing a fluid-filled, shape-changing base with an exchangeable fixed-power front optic
— designed to work with the eye''s natural accommodative mechanism to restore a full range of functional vision in cataract
patients, and implanted using conventional cataract surgical technique. The company raised a $20M Series D and a $42M Series
E, and in May 2025 the U.S. Food and Drug Administration granted it an Investigational Device Exemption to begin a feasibility
clinical study of the OmniVu Lens System; the device is investigational and is not approved for sale or use in the United
States. Atia Vision is an implantable-device manufacturer: it publishes no developer program, no public API, and no machine-readable
specification.'
url: https://raw.githubusercontent.com/api-evangelist/atia-vision/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-listing: https://forgeglobal.com/atia-vision_stock/
x-tier: stub
x-tier-reason: harvest
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
specificationVersion: '0.23'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Medical Devices
- Ophthalmology
- Intraocular Lens
- Cataract Surgery
- Health
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
x-enrichment:
date: '2026-08-06'
status: minimal
artifacts_added: 1
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: 'Atia Vision is a clinical-stage implantable-device maker whose product is the OmniVu intraocular lens, not software
— no api./docs./developer./portal. host resolves in DNS, no atiavision GitHub organization exists, no npm/PyPI package
is published, and every path on the marketing site (including a random control path) is answered identically by a SiteGround
`sg-captcha: challenge` interstitial, so there is no developer surface to read behind it either.'
evidence:
- url: https://api.github.com/orgs/atiavision
status: 404
- url: https://atiavision.com/openapi.json
status: 202
- url: https://atiavision.com/.well-known/agent-card.json
status: 202
- url: https://registry.npmjs.org/atia-vision
status: 404
checked: '2026-08-06'
common:
- type: DomainSecurity
url: security/atia-vision-domain-security.yml
- type: Website
url: https://atiavision.com/
- type: LinkedIn
url: https://www.linkedin.com/company/atia-vision
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →